Oxford University and Brazil’s Health Ministry Partner to Boost Cancer Vaccine Development

The two‌ countries have already worked together on vaccine research during the Covid-19 pandemic

The Ministry‌ of Health‌ has formalized an⁤ agreement ⁤with the University of Oxford for‌ the development of vaccines to⁤ prevent cancer. The partnership seeks to accelerate the creation of innovative immunological therapies,⁢ expand equitable access and strengthen the scientific and technological ⁢capacity of both countries in mRNA technologies ⁤and artificial intelligence​ for scientific discovery.

The signing of⁤ the⁢ Letter of Intent​ between the Ministry of Health and the Center for Immuno-oncology at the University of Oxford in the United Kingdom also included representatives from the National Center for Research​ in Energy and Materials (CNPEM), Fiocruz and leading ⁣Brazilian hospitals, who will integrate the cooperation. other institutions, such as the National Cancer Institute (INCA), will be invited to participate in‌ the next stages.

For ​the secretary of ‍ Science, Technology and innovation⁣ in Health,​ Fernanda De Negri, “This agreement, driven ‍by the Ministry of Health, opens a very vital window of⁢ opportunity for research ⁣institutions, leading ⁣hospitals and Brazilian companies to participate, from very early on, in studies on vaccines for cancer. This ‌puts​ us in a more ⁣advantageous position when these vaccines eventually reach‍ the market.”

:0px;padding-bottom:0px;padding-left:0px”>